These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 12489491

  • 1. Rituximab for refractory childhood autoimmune hemolytic anemia.
    Motto DG, Williams JA, Boxer LA.
    Isr Med Assoc J; 2002 Nov; 4(11):1006-8. PubMed ID: 12489491
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
    Erdozain JG, Ruiz-Irastorza G, Egurbide MV, Aguirre C.
    Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
    [Abstract] [Full Text] [Related]

  • 4. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F, Iacona I, Masolini P, Russo D, Sperotto A, Prosdocimo S, Patriarca F, de Vita S, Regazzi M, Baccarani M, Fanin R.
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [Abstract] [Full Text] [Related]

  • 5. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
    D'Arena G, Laurenti L, Capalbo S, D'Arco AM, De Filippi R, Marcacci G, Di Renzo N, Storti S, Califano C, Vigliotti ML, Tarnani M, Ferrara F, Pinto A.
    Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
    [Abstract] [Full Text] [Related]

  • 6. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
    D'Arena G, Califano C, Annunziata M, Tartarone A, Capalbo S, Villani O, Amendola G, Pietrantuono G, Ferrara F, Pinto A, Musto P, D'Arco AM, Cascavilla N.
    Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766
    [Abstract] [Full Text] [Related]

  • 7. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
    Gentile M, Lucia E, Iorio C, Vigna E, Mazzone C, Morelli R, Bisconte MG, Gentile C, Morabito F.
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
    [Abstract] [Full Text] [Related]

  • 8. The successful treatment of refractory autoimmune hemolytic anemia with rituximab in a patient with chronic lymphocytic leukemia.
    Pamuk GE, Turgut B, Demir M, Tezcan F, Vural O.
    Am J Hematol; 2006 Aug; 81(8):631-3. PubMed ID: 16906592
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P, Bjerrum OW, Nielsen OJ, Jensen BA, Clausen NT, Hansen PB, Andersen I, Schmidt K, Andersen TM, Peterslund NA, Birgens HS, Plesner T, Pedersen BB, Hasselbalch HC.
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Rituximab for the treatment of post-bone marrow transplantation refractory hemolytic anemia in a child with Omenn's syndrome.
    Silvana B, Antonella LM, Basilia P, Trombetta D, Saija A, Salpietro C.
    Pediatr Transplant; 2007 Aug; 11(5):552-6. PubMed ID: 17631027
    [Abstract] [Full Text] [Related]

  • 14. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
    Gupta N, Kavuru S, Patel D, Janson D, Driscoll N, Ahmed S, Rai KR.
    Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
    [Abstract] [Full Text] [Related]

  • 15. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
    Rao A, Kelly M, Musselman M, Ramadas J, Wilson D, Grossman W, Shenoy S.
    Pediatr Blood Cancer; 2008 Apr; 50(4):822-5. PubMed ID: 17570702
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
    Perrotta S, Locatelli F, La Manna A, Cennamo L, De Stefano P, Nobili B.
    Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453
    [Abstract] [Full Text] [Related]

  • 18. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient.
    Endo T, Nakao S, Koizumi K, Nishio M, Fujimoto K, Sakai T, Kumano K, Obara M, Koike T.
    Ann Hematol; 2004 Feb; 83(2):114-6. PubMed ID: 14513283
    [Abstract] [Full Text] [Related]

  • 19. Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature.
    Gorelik M, Debski R, Frangoul H.
    J Pediatr Hematol Oncol; 2004 Dec; 26(12):837-9. PubMed ID: 15591908
    [Abstract] [Full Text] [Related]

  • 20. Rituximab in the treatment of refractory autoimmune cytopenias in adults.
    Narat S, Gandla J, Hoffbrand AV, Hughes RG, Mehta AB.
    Haematologica; 2005 Sep; 90(9):1273-4. PubMed ID: 16154853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.